Symberix

United States · 5 Employees
Symberix, an early-stage spin-out of the University of North Carolina at Chapel Hill, aims to improve human health by pioneering the development of symbiotic drugs that work by controlling bacteria without killing them. Symberix's scientific founder, Matthew Redinbo, PhD, was the first to demonstrate the feasibility of therapeutically controlling the mammalian microbiome with small-molecule symbiotic drugs. Based on this breakthrough research, the company is advancing a first-in-class approach to improve the treatment of serious lower gastrointestinal (GI) diseases as well as mitigate the debilitating lower GI side effects associated with various cancer, pain, and immunosuppressive therapies. Symberix's internal team and scientific/clinical/business advisors have a deep understanding of the microbiome as well as extensive drug discovery, clinical development and commercial biopharma experience. Our vision: Safe and effective pharmaceutical control of the microbiome.

概述

国家 United States
成立时间 2013
总部 4819 Emperor Blvd., 400, Research Triangle Park, NC 27703, US
电话号码 +1 919 843 3304
网站 http://www.symberix.net
LinkedIn http://www.linkedin.com/company/symberix
Twitter
Facebook
员工数 5
行业 research,
简介 Symberix, an early-stage spin-out of the University of North Carolina at Chapel Hill, aims to improve human health by pioneering the development of symbiotic drugs that work by controlling bacteria without killing them. Symberix's scientific founder, Matthew Redinbo, PhD, was the first to demonstrate the feasibility of therapeutically controlling the mammalian microbiome with small-molecule symbiotic drugs. Based on this breakthrough research, the company is advancing a first-in-class approach to improve the treatment of serious lower gastrointestinal (GI) diseases as well as mitigate the debilitating lower GI side effects associated with various cancer, pain, and immunosuppressive therapies. Symberix's internal team and scientific/clinical/business advisors have a deep understanding of the microbiome as well as extensive drug discovery, clinical development and commercial biopharma experience. Our vision: Safe and effective pharmaceutical control of the microbiome.

技术

Microsoft Office 365

Other

NSOne

Domain Name Services

Outlook

Email Providers

Typekit

Fonts

YouTube

Online Video Platforms

常见问题

Symberix 在哪里?

Symberix 的总部位于 4819 Emperor Blvd., 400, Research Triangle Park, NC 27703, US

Symberix 的电话号码是多少?

Symberix 的电话号码是 +1 919 843 3304

Symberix 的官方网站是什么?

Symberix 的公司官方网站是 http://www.symberix.net

Symberix 是做什么的?

Symberix 的业务有哪些?

microbiome,biotechnology,drug discovery

Symberix 的年收入是多少?

Symberix 的收入是 0美元

Symberix 有多少员工?

Symberix 有 5 名员工

Symberix 属于哪个行业?

Symberix 从事以下行业: research

Symberix 使用什么技术?

Symberix 使用的一些流行技术包括: Microsoft Office 365,NSOne,Outlook,Typekit,YouTube

如何联系 Symberix?

Symberix 联系信息: 电话号码:+1 919 843 3304， 网站:http://www.symberix.net， 邮箱：wen***@***.com

Symberix 的社交媒体链接是什么?

Symberix 领英：http://www.linkedin.com/company/symberix,fackbook：,twitte:

Symberix 是一家上市公司吗?

不是

Symberix 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 Symberix?

Symberix 有 0 家投资者,包括 。

管理层

Wendy Anders

Senior Manager, Executive Administration and Scientific Operations

Bret Wallace

Director

员工

Andy

Associate Research Scientist

外贸获客 查找关键决策人

10亿+海关交易数据，1.2亿企业数据，2亿+企业联系人数据，1000千万真实采购商。覆盖200+个国家及地区，95%外贸重点拓展市场，可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少，成就更大，销售更聪明

查找更多 B2B 联系人，丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google